George Cardoza, Chief Financial Officer at SOPHiA GENETICS SA (SOPH), sold 774 shares at $5.38 ($4K) on 2026-06-22, disclosed to the SEC on 2026-06-23.
Scheduled sale ($4k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| SOPH | SELL | 2026-04-10 | $7K | — | Filing → |
| SOPH | SELL | 2026-04-08 | $24K | — | Filing → |
| SOPH | SELL | 2026-03-20 | $7K | — | Filing → |